Institutional Ownership Rocket Pharmaceuticals, Inc. (RCKT)
This table provides information about the institutional ownership of Rocket Pharmaceuticals, Inc. (RCKT). We have compiled data on the 244 institutions that hold shares in the stock, with a total of 108 Million shares, which have been reported (via 13F filing form) to have a value of $1.18 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Rtw Investments, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
17,687,772
shares
|
$192 Million
3.63% of portfolio
|
Q4 2022
Added 11.93%
|
|
Wellington Management Group LLP
Boston, MA |
Feb 12, 2025 Q4 2024 |
13,995,177
shares
|
$152 Million
0.03% of portfolio
|
Q4 2024
Added 24.49%
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
6,577,595
shares
|
$71.5 Million
0.0% of portfolio
|
Q4 2024
Added 18.79%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
6,192,627
shares
|
$67.3 Million
0.0% of portfolio
|
Q2 2024
Added 4.43%
|
|
Lee Ainslie
Maverick Capital LTD | Dallas, Tx
|
Feb 14, 2025 Q4 2024 |
5,198,900
shares
|
$56.5 Million
1.26% of portfolio
|
Q4 2024
Added 26.23%
|
|
Westfield Capital Management CO LP
Boston, MA |
Feb 11, 2025 Q4 2024 |
4,714,610
shares
|
$51.2 Million
0.27% of portfolio
|
Q4 2024
Added 4.91%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Feb 14, 2025 Q4 2024 |
4,122,824
shares
|
$44.8 Million
0.01% of portfolio
|
Q4 2024
Added 91.93%
|
|
Janus Henderson Group PLC
London, X0 |
Feb 14, 2025 Q4 2024 |
4,004,039
shares
|
$43.5 Million
0.03% of portfolio
|
Q4 2024
Added 111.03%
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
3,458,079
shares
|
$37.6 Million
0.0% of portfolio
|
Q4 2024
Added 11.48%
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
3,148,520
shares
|
$34.2 Million
0.0% of portfolio
|
Q4 2024
Reduced 1.85%
|
|
Suvretta Capital Management, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
2,566,951
shares
|
$27.9 Million
1.34% of portfolio
|
Q4 2024
New holding
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
1,752,975
shares
|
$19.1 Million
0.0% of portfolio
|
Q4 2024
Added 8.35%
|
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
Feb 14, 2025 Q4 2024 |
1,569,823
shares
|
$17.1 Million
0.05% of portfolio
|
Q4 2024
Added 3163.94%
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
Feb 14, 2025 Q4 2024 |
1,479,025
shares
|
$16.1 Million
1.11% of portfolio
|
Q4 2024
Reduced 0.44%
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
Feb 12, 2025 Q4 2024 |
1,317,969
shares
|
$14.3 Million
0.02% of portfolio
|
Q4 2024
Reduced 4.96%
|
|
Avoro Capital Advisors LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
1,200,000
shares
|
$13 Million
0.22% of portfolio
|
Q4 2024
New holding
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
1,184,709
shares
|
$12.9 Million
0.0% of portfolio
|
Q4 2024
Added 92.47%
|
|
Novo Holdings
Hellerup, G7 |
Feb 14, 2025 Q4 2024 |
1,100,000
shares
|
$12 Million
1.12% of portfolio
|
Q2 2024
Added 4.76%
|
|
Toronto Dominion Bank
Toronto, Ontario, A6 |
Feb 19, 2025 Q4 2024 |
1,100,000
shares
|
$12 Million
0.02% of portfolio
|
Q4 2024
New holding
|
|
Prosight Management, LP
Dallas, TX |
Feb 14, 2025 Q4 2024 |
1,088,706
shares
|
$11.8 Million
4.06% of portfolio
|
Q4 2024
Added 583.14%
|
|
Putnam Investments LLC
Boston, MA |
Feb 14, 2024 Q4 2023 |
1,069,715
shares
|
$11.6 Million
0.04% of portfolio
|
Q4 2023
Added 7.05%
|
|
Avidity Partners Management LP
Dallas, TX |
Feb 14, 2025 Q4 2024 |
1,053,300
shares
|
$11.4 Million
1.5% of portfolio
|
Q4 2024
Added 40.63%
|
|
Bio Impact Capital LLC
Cambridge, MA |
Feb 14, 2025 Q4 2024 |
1,020,559
shares
|
$11.1 Million
1.92% of portfolio
|
Q4 2024
Reduced 4.3%
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
802,785
shares
|
$8.73 Million
0.0% of portfolio
|
Q4 2024
Added 89.3%
|
|
Russell Investments Group, Ltd.
|
Feb 13, 2025 Q4 2024 |
791,877
shares
|
$8.61 Million
0.01% of portfolio
|
Q4 2024
Reduced 2.52%
|